MASP1 and systemic inflammatory response syndrome: Patients with MAp44 levels ≤1.81 μg/ml more frequently experienced low cardiac output syndrome (LCOS), renal insufficiency, systemic inflammatory response syndrome (SIRS) and multiorgan dysfunction (MODS).